Angiotensin Converting Enzyme Inhibitors, A Risk Factor of Poor Outcome in Diabetic Patients with COVID-19 Infection. Iranian Journal of Kidney Diseases, [S. l.], v. 14, n. 6, p. 482–487, 2020. Disponível em: https://ijkd.org/index.php/ijkd/article/view/5920. Acesso em: 29 apr. 2025.